Skip to main navigation Skip to search Skip to main content

ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy

On behalf of the ROBIN study investigators*, Vall d’Hebron University Hospital, CHLC - Hospital Santo António dos Capuchos

Research output: Contribution to journal › Article › peer-review

4   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathy'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience